Biblio

Found 20 results
Author Keyword Title [ Type(Desc)] Year
Filters: Author is Sergio Pecorelli  [Clear All Filters]
Journal Article
A. du Bois, Quinn, M., Thigpen, T., Vermorken, J. B., Åvall-Lundqvist, E., Bookman, M. A., Bowtell, D. D. L., Brady, M. F., Casado, A., Cervantes, A., Eisenhauer, E., Friedlander, M. Leonard, Fujiwara, K., Grenman, S., Guastalla, J. P., Harper, P., Högberg, T., Kaye, S. B., Kitchener, H. C., Kristensen, G. B., Mannel, R., Meier, W., Miller, B., Neijt, J. P., Oza, A. M., Ozols, R., Parmar, M. K. B., Pecorelli, S., Pfisterer, J., Poveda, A. M., Provencher, D. M., Pujade-Lauraine, E., Randall, M., Rochon, J., Rustin, G. J. S., Sagae, S., Stehman, F. B., Stuart, G. C. E., Trimble, E. L., Vasey, P. A., Vergote, I. B., Verheijen, R. H. M., and Wagner, U., 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)., Ann Oncol, vol. 16 Suppl 8, pp. viii7-viii12, 2005.
B. K, Kaern, J., Simonsen, E., Piccart, M. J., G, H. Boes, Timmers, P., Roy, J. - A., Pecorelli, S., Stuart, G. C. E., James, K., Cassidy, J., and Kaye, S. B., Is cisplatin-taxol the standard treatment in advanced ovarian cancer., Eur.J.Can. , vol. 33, no. 8, 1997.
J. B. Vermorken and Pecorelli, S., Clinical trials in patients with epithelial ovarian cancer: past, present and future., Eur J Surg Oncol, vol. 22, no. 5, pp. 455-66, 1996.
M. E. L. van der Burg, van Lent, M., Buyse, M., Kobierska, A., Colombo, N., Favalli, G., Lacave, A. J., Nardi, M., Renard, J., and Pecorelli, S., The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer, N Engl J Med, vol. 332, pp. 629-34, 1995.
A. Casado, Penninckx, B., Reed, N. Simon, van der Burg, M. E. L., Berns, E. M. J. J., Katsaros, D., Ferrero, A., Fernando, M., Jimeno, A., Vermorken, J. B., Pecorelli, S., and Vergote, I. B., EORTC Gynecological Cancer Group on the frontline of practice-changing clinical trials. , European Journal Cancer , vol. 10, no. 1, p. 73, 2012.
C. Mangioni, Malmström, H., Reed, N. Simon, Scarfone, G., Poveda, A. M., Tateo, S., Pecorelli, S., Vergote, I. B., Giurgea, L., Coens, C., and Teodorovic, I., First results of a randomised trial comparing radiotherapy - versus - observation post operatively in patients with uterine sarcomas., Int J Gynecol Cancer , vol. 13, no. Suppl 1, 2003.
J. B. Trimbos, Vergote, I. B., Bolis, G., Vermorken, J. B., Mangioni, C., Madronal, C., Franchi, M., Tateo, S., Zanetta, G., Scarfone, G., Giurgea, L., Timmers, P., Coens, C., Pecorelli, S., Collaborators, E. O. R. T. C. - A. C. T. I. O. N., Research, E. Organisati, and Neoplasm, Tof Cancer-, Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial, J Natl Cancer Inst, vol. 95, pp. 113-25, 2003.
M. Quinn, Pfisterer, J., Åvall-Lundqvist, E., Bookman, M. A., Bowtell, D. D. L., Casado, A., Cervantes, A., Grenman, S., Harper, P., Oza, A. M., Pecorelli, S., Pujade-Lauraine, E., Trimble, E. L., Vasey, P. A., and Wagner, U., Integration of new or experimental treatment options and new approaches to clinical trials., Ann Oncol, vol. 16 Suppl 8, pp. viii30-viii35, 2005.
M. Quinn, Pfisterer, J., Åvall-Lundqvist, E., Bookman, M. A., Bowtell, D. D. L., Casado, A., Cervantes, A., Grenman, S., Harper, P., Oza, A. M., Pecorelli, S., Pujade-Lauraine, E., Trimble, E. L., Vasey, P. A., Wagner, U., ,, -OVAR, A. G. O., ,, ,, ,, ,, /NCRI, M. R. C., -CTG, N. C. I. C., ,, ,, -US, N. C. I., and , Integration of new or experimental treatment options and new approaches to clinical trials, Ann Oncol, vol. 16 Suppl 8, pp. viii30-viii35, 2005.
J. B. Trimbos, Parmar, M. K. B., Vergote, I. B., Guthrie, D., Bolis, G., Colombo, N., Vermorken, J. B., Torri, V., Mangioni, C., Pecorelli, S., Lissoni, A., Swart, A. Marie, Neoplasm, I. Collaborat, Research, E. Organisati, and Neoplasm, Tof Cancer, International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma, J Natl Cancer Inst, vol. 95, pp. 105-12, 2003.
M. J. Piccart, Bertelsen, K., Stuart, G. C. E., Cassidy, J., Mangioni, C., Simonsen, E., James, K., Kaye, S. B., Vergote, I. B., Blom, R., Grimshaw, R., Atkinson, R. J., Swenerton, K. D., Tropé, C. G., Nardi, M., Kaern, J., Tumolo, S., Timmers, P., Roy, J. - A., Lhoas, F., Lidvall, B., Bacon, M., Birt, A., Andersen, J. E., Zee, B., Paul, J., Pecorelli, S., Baron, B., and McGuire, W. P., Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer, Int J Gynecol Cancer, vol. 13 Suppl 2, pp. 144-8, 2003.
M. J. Piccart, Bertelsen, K., Stuart, G. C. E., Cassidy, J., Mangioni, C., Simonsen, E., James, K., Kaye, S. B., Vergote, I. B., Blom, R., Grimshaw, R., Atkinson, R. J., Swenerton, K. D., Tropé, C. G., Nardi, M., Kaern, J., Tumolo, S., Timmers, P., Roy, J. - A., Lhoas, F., Lidvall, B., Bacon, M., Birt, A., Andersen, J. E., Zee, B., Paul, J., Pecorelli, S., Baron, B., and McGuire, W. P., Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer., Int J Gynecol Cancer, vol. 13 Suppl 2, pp. 144-8, 2003.
I. B. Vergote, Tropé, C. G., Amant, F., Kristensen, G. B., Ehlen, T., Johnson, N., Verheijen, R. H. M., van der Burg, M. E. L., Lacave, A. J., Panici, P. Benedetti, Kenter, G. G., Casado, A., Mendiola, C., Coens, C., Verleye, L., Stuart, G. C. E., Pecorelli, S., and Reed, N. Simon, Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer., N Engl J Med, vol. 363, no. 10, pp. 943-53, 2010.
S. Pecorelli, Ray-Coquard, I., Tredan, O., Colombo, N., Parma, G., Tisi, G., Katsaros, D., Lhommé, C., Lissoni, A., Vermorken, J. B., du Bois, A., Poveda, A. M., Frigerio, L., Barbieri, P., Carminati, P., Brienza, S., and Guastalla, J. P., Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes., Ann Oncol, vol. 21, no. 4, pp. 759-65, 2010.
H. C. Wagenaar, Pecorelli, S., Vergote, I. B., Curran, D., Wagener, D. J., Kobierska, A., Bolis, G., Bokkel-Huinink, W. T., Lacave, A. J., Madronal, C., Forn, M., de Oliveira, C. F., Mangioni, C., Nooij, M. A., Goupil, A., Kerbrat, P., Marth, C. H., Tumolo, S., Herben, M. G., Zanaboni, F., and Vermorken, J. B., Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer., Eur J Gynaecol Oncol, vol. 22, no. 3, pp. 187-93, 2001.
H. C. Wagenaar, Pecorelli, S., Vergote, I. B., Curran, D., Wagener, D. J., Kobierska, A., Bolis, G., Bokkel-Huinink, W. T., Lacave, A. J., Madronal, C., Forn, M., de Oliveira, C. F., Mangioni, C., Nooij, M. A., Goupil, A., Kerbrat, P., Marth, C. H., Tumolo, S., Herben, M. G., Zanaboni, F., and Vermorken, J. B., Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer, Eur J Gynaecol Oncol, vol. 22, pp. 187-93, 2001.
N. Simon Reed, Mangioni, C., Malmström, H., Scarfone, G., Poveda, A. M., Pecorelli, S., Tateo, S., Franchi, M., Jobsen, J. J., Coens, C., Teodorovic, I., Vergote, I. B., and Vermorken, J. B., Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)., Eur J Cancer, vol. 44, no. 6, pp. 808-18, 2008.
M. J. Piccart, Bertelsen, K., James, K., Cassidy, J., Mangioni, C., Simonsen, E., Stuart, G. C. E., Kaye, S. B., Vergote, I. B., Blom, R., Grimshaw, R., Atkinson, R. J., Swenerton, K. D., Tropé, C. G., Nardi, M., Kaern, J., Tumolo, S., Timmers, P., Roy, J. - A., Lhoas, F., Lindvall, B., Bacon, M., Birt, A., Andersen, J. E., Zee, B., Paul, J., Baron, B., and Pecorelli, S., Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results, J Natl Cancer Inst, vol. 92, pp. 699-708, 2000.
M. J. Piccart, Bertelsen, K., James, K., Cassidy, J., Mangioni, C., Simonsen, E., Stuart, G. C. E., Kaye, S. B., Vergote, I. B., Blom, R., Grimshaw, R., Atkinson, R. J., Swenerton, K. D., Tropé, C. G., Nardi, M., Kaern, J., Tumolo, S., Timmers, P., Roy, J. - A., Lhoas, F., Lindvall, B., Bacon, M., Birt, A., Andersen, J. E., Zee, B., Paul, J., Baron, B., and Pecorelli, S., Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results., J Natl Cancer Inst, vol. 92, no. 9, pp. 699-708, 2000.
B. Trimbos, Timmers, P., Pecorelli, S., Coens, C., Ven, K., van der Burg, M. E. L., and Casado, A., Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial., J Natl Cancer Inst, vol. 102, no. 13, pp. 982-7, 2010.